Kamada
Manufacturing · Israel · 201-500 Employees
View Company Info for Free
Overview
Headquarters
2 Holzman Street Science Park, Rehovot, ...Phone Number
+972 89406472Website
www.kamada.comRevenue
$181.7 MillionStock Symbol
KMDAIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Kamada
Kamada Ltd. is a commercial-stage biopharmaceutical company specializing in the development, manufacturing, and commercialization of plasma-derived therapeutics for the treatment of rare and serious medical conditions. The company focuses on producing specialty biologic products that address unmet medical needs while providing life-saving therapies for patients affected by immune deficiencies, infectious diseases, pulmonary disorders, and other complex health conditions. Through decades of scientific expertise in plasma-derived technologies, Kamada has established itself as an internationally recognized manufacturer and supplier of specialized therapeutic products distributed across numerous global healthcare markets.Explore more
Kamada Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Kamada your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Kamada launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Kamada, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Kamada has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Kamada recently announced quarterly report
Funding: Get notified immidiatlly once Kamada has new funding data
Click to see if Kamada had a recent Job posting/layoffs
Check out if Kamada is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Kamada
Recommended Actions
Find VP level buyers at Kamada
Find 2 more new buyers
Company Profile Activity
Activity Insights
Kamada is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Kamada is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Kamada.
Kamada financials insights
Gather financial insights about Kamada, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Share Placement
$25M
2022
Other Financing Round
$11.4M
Kamada Tech Stack
A closer look at the technologies used by Kamada
See more technologies
Most Recent Scoops
Hiring Plans
Kamada Pharmaceuticals has more open roles in Operations than it has had at any time in the past 12 months.
Hiring Plans
Hiring Plans
Kamada Pharmaceuticals has more open roles in Medical & Health than it has had at any time in the past 9 months.
Hiring Plans
Earnings
reported gross profit and gross margins for fiscal year 2025 of $76.4 million and 42% respectively, compared to $70 million and 43% respectively in fiscal year 2024. The increase in gross profit is in line with the increase in total revenues, whereas the decrease in gross margin is due to product and market sales mix.
Earnings, Finance
Earnings
reported net income of $20.2 million or $0.35 per diluted share for fiscal year 2025, a 40% increase as compared to net income of $14.5 million or $0.25 per diluted share in fiscal year 2024.
Earnings, Accounting, Financial Reporting, Finance
Earnings
Earnings, Finance
Kamada News & Media
Kamada Reports Record-High First Half and Second Quarter 2026 Financial Results, Representing Double-Digit Profitable Growth and the Strongest in Kamada's History; Affirms 2026 Annual Guidance
REHOVOT, Israel and HOBOKEN, N.J., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived therapies field, today announced financial results for the three months and six months ended June 30, 2026.Kamada Announces Planned Transition of Chief Financial Officer
REHOVOT, Israel, and HOBOKEN, N.J., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived therapies field, today announced that Chaime Orlev, its Chief Financial Officer (CFO), will transition out of his role to pursue other opportunities, effective December 31, 2026. Kamada has a search underway to identify a succeKamada to Announce Second Quarter and First Half Ended June 30, 2026 Financial Results on August 12, 2026
Company to Host Conference Call at 8:30am ET Company to Host Conference Call at 8:30am ETKamada Announces a Three-Year $50 Million Sales Agreement to Supply Plasma to a Leading Biopharmaceutical Company focused on Plasma-derived Therapies
REHOVOT, Israel and HOBOKEN, N.J., July 20, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, today announced an agreement to supply plasma to a leading biopharmaceutical company focused on plasma-derived therapies. The new three-year agreement for the supply of normal source plasma from Kamada’s plasma collection
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Kamada
Sign Up For FreeTo access detailed company insights
Kamada Ltd. is a commercial-stage biopharmaceutical company specializing in the development, manufacturing, and commercialization of plasma-derived therapeutics for the treatment of rare and serious medical conditions. The company focuses on producing specialty biologic products that address unmet medical needs while providing life-saving therapies... Read More
